Sidenav Mini


MONEY MONDAY May 16th 2022 Morning Stock Newsletter

🌟 Goooood Morning Traders and Happy Money Monday 🌟

I hope everyone had a fantastic weekend and that you are fired up 🔥 for a great day ahead!

Today marks the start of a brand new day and a brand new week full of brand new opportunities 💪

Last week was an amazing week inside of chat and in the market. I am excited to see what the market has in store for us this week and to make this the best week of the year yet!

Yesterdays trader of the day – Allen with a $800+ profit and $3,280 for the week! WWWOOOOO


Bear market, GDP, and Davos: What to watch this week

Stock futures rise as Wall Street attempts to rebound after relentless sell-off

$GOVX – On May 26 , Don Diamond , PhD, professor in City of Hopes Department of Hematology & Hematopoietic Transplantation , and the lead original developer of GeoVaxs vaccine against COVID-19 (GEO-CM04S1, formerly known as COH04S1) currently being evaluated in two Phase 2 clinical trials, will deliver a presentation titled, Conception, Construction, Pre-Clinical & Clinical Testing of COH04S1 Vaccine with Activity Against SARS-CoV-2.

$OCGN – Ocugen, Inc. to Present at H.C. Wainwright Global Investment Conference (Ocugen gains as FDA lifts clinical hold on trial for COVID-19 shot)

$PRTG – US FDA Accepts for Review Biohaven’s New Drug Application (NDA) Filing of Intranasal Zavegepant for the Acute Treatment of Migraine

$SNGX – Soligenix Receives US Patent Allowance for its Thermostabilized Vaccine Platform

$JAGX – Jaguar Health Announces Launch of the First U.S. Canine Cancer Registry and Canine Cancer Care Index

$WKHS – Workhorse Group Assigned Patent for Flying Vehicle Systems

My top stocks for the day
We need to be looking for press releases that have to do with “monkeypox”. That could be our next big play as $SIGA has a press release Thursday ( U.S. Food and Drug Administration (FDA) approved the intravenous (IV) formulation of TPOXX for the treatment of smallpox. The IV formulation is an important option for those who are unable to swallow the oral capsules of TPOXX.)

$SIGA is the #1 stock to watch at this time. We hit it on the head when we discussed how real a short squeeze was! I hope you were all playing this to the long side as we discussed Friday. ATH on $SIGA is $15.21. Let’s see if we can hold this level in pre-market. Resistance is back up at $17.50. If we crack below $15.21 and $15.00, we have room to fall back down to Fridays highs/close at $12.40



Earnings this Week